文献速递心血管MRCTPETDSA

稳定性胸痛综合征负荷心血管磁共振成像的成本效果分析

Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes.
PubMed 文献 · JACC Cardiovasc Imaging · 2020-05-13

基于多中心SPINS研究,用决策分析模型比较负荷心血管磁共振(CMR)优先策略与立即X线冠状动脉造影、单光子发射计算机断层扫描、冠状动脉计算机断层扫描血管造影及无成像4种策略的成本效果。作者结论认为,在有创X线冠状动脉造影之前,负荷CMR可能是有阻塞性冠状动脉疾病风险患者的一种成本有效的把关工具。

要点

  • 在疑似稳定性胸痛患者中,负荷CMR优先策略相比无成像策略的增量成本效果比为每质量调整生命年52000美元。
  • 结果对疾病患病率、冠状动脉疾病治疗的风险比及年贴现率的模型输入变化敏感。

诊断标准与关键数值

  • 以硬心血管事件(心血管死亡或急性心肌梗死)为终点,每人总费用最低为无成像策略(16936美元),最高为立即X线冠状动脉造影策略(20929美元)。
  • 终生质量调整生命年最低为无成像策略(12.72050),最高为立即X线冠状动脉造影策略(12.76535)。
  • CMR策略相比无成像策略的增量成本效果比为每质量调整生命年52000美元。

局限性

  • 结果对疾病患病率、冠状动脉疾病治疗的风险比及年贴现率的模型输入变化敏感。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to compare, using results from the multicenter SPINS (Stress CMR Perfusion Imaging in the United States) study, the incremental cost-effectiveness of a stress cardiovascular magnetic resonance (CMR)-first strategy against 4 other clinical strategies for patients with stable symptoms suspicious for myocardial ischemia: 1) immediate x-ray coronary angiography (XCA) with selective fractional flow reserve for all patients; 2) single-photon emission computed tomography; 3) coronary computed tomographic angiography with selective computed tomographic fractional flow reserve; and 4) no imaging.

BACKGROUND: Stress CMR perfusion imaging has established excellent diagnostic utility and prognostic value in coronary artery disease (CAD), but its cost-effectiveness in current clinical practice has not been well studied in the United States.

METHODS: A decision analytic model was developed to project health care costs and lifetime quality-adjusted life years (QALYs) for symptomatic patients at presentation with a 32.4% prevalence of obstructive CAD. Rates of clinical events, costs, and quality-of-life values were estimated from SPINS and other published research. The analysis was conducted from a U.S. health care system perspective, with health and cost outcomes discounted annually at 3%.

RESULTS: Using hard cardiovascular events (cardiovascular death or acute myocardial infarction) as the endpoint, total costs per person were lowest for the no-imaging strategy ($16,936) and highest for the immediate XCA strategy ($20,929). Lifetime QALYs were lowest for the no-imaging strategy (12.72050) and highest for the immediate XCA strategy (12.76535). The incremental cost-effectiveness ratio for the CMR-based strategy compared with the no-imaging strategy was $52,000/QALY, whereas the incremental cost-effectiveness ratio for the immediate XCA strategy was $12 million/QALY compared with CMR. Results were sensitive to variations in model inputs for prevalence of disease, hazard rate ratio for treatment of CAD, and annual discount rate.

CONCLUSIONS: Prior to invasive XCA, stress CMR can be a cost-effective gatekeeping tool in patients at risk for obstructive CAD in the United States. (Stress CMR Perfusion Imaging in the United States [SPINS] Study; NCT03192891.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Ge Y, Pandya A, Steel K, et al. Cost-Effectiveness Analysis of Stress Cardiovascular Magnetic Resonance Imaging for Stable Chest Pain Syndromes. JACC Cardiovasc Imaging. 2020. PMID: 32417337. doi:10.1016/j.jcmg.2020.02.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。